POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company Jun 30, 2021 04:05PM
POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company Jun 30, 2021 04:05PM
POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I (RACA) Mar 15, 2021 06:35AM